| Financial Year |
March 31 2023 |
| Monetary Funds |
968,576,158.15 |
| Held-for-trading Financial Assets |
84,180,012.21 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,362,315,114.27 |
| Advances to Suppliers |
112,535,384.07 |
| Other Receivables |
48,991,686.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,451,277,380.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,120,521,533.08 |
| Total Current Assets |
17,541,429,013.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
170,794,417.34 |
| Long-term Equity Investment |
645,117,305.84 |
| Investment Properties |
282,604,181.08 |
| Fixed Assetes |
1,835,611,749.07 |
| Under-construction Projects |
65,175,673.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
410,153,307.68 |
| R&D expenses |
-- |
| Goodwill |
1,414,221.35 |
| Long-Term Deferred and Prepaid Expenses |
26,669,042.51 |
| Deferred Income Tax Assets |
18,414,869.12 |
| Other Non-Current Assets |
32,086,248.54 |
| Sub-Total of Non-Current Assets |
5,445,458,681.20 |
| Total Assets |
22,986,887,694.45 |
| Short-Term Loans |
2,546,136,360.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
287,579,065.48 |
| Accounts Payable |
2,070,970,917.52 |
| Accounts Received In Advance |
73,162,885.17 |
| Employee Compensation Payable |
51,948,810.27 |
| Taxes Payable |
2,885,514,611.03 |
| Interest Payable |
-- |
| Dividend Payable |
5,470,156.72 |
| Other payables |
2,058,380,714.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,320,296,163.54 |
| Other Current Liabilities |
220,105,481.31 |
| Sub-Total of Current Liabilities |
13,157,257,077.96 |
| Long-term Loans |
1,277,454,966.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
559,322.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,202,407.77 |
| Deferred Income Tax Liabilities |
27,153,247.58 |
| Other Non-Current Liabilities |
173,547,833.83 |
| Sub-Total of Non-Current Liabilities |
1,491,604,566.71 |
| Total Liabilities |
14,648,861,644.67 |
| Paid-In Capital(Or Share Stock) |
1,391,668,739.00 |
| Capital Surplus |
961,869,870.27 |
| Surplus Reserve |
605,041,974.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,056,183,151.53 |
| Minority Stockholder's Interest |
1,319,855,737.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,018,170,312.74 |
| Owner's Equity（Stockholder's Equity） |
8,338,026,049.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,986,887,694.45 |
